SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-22-007274
Filing Date
2022-09-28
Accepted
2022-09-28 12:06:10
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 13984
  Complete submission text file 0001477932-22-007274.txt   15497
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915
Business Address
Harness Jane A. (Reporting) CIK: 0001702800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 221273706